Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119858 · ClinicalTrials.gov registry record · Phase 1
Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery
A Phase 1 study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT02119858 is a Phase 1 study that has completed, run by City of Hope Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT02119858, a Phase 1 study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This clinical trial studies diffuse optical imaging with indocyanine green solution in imaging pelvic lymph nodes in patients with stage II prostate cancer undergoing surgery. Indocyanine green solution is a special dye that can help doctors see the lymph nodes and blood vessels during surgery when visualized under diffuse optical imaging. Indocyanine green solution may improve the ability to detect lymph nodes and may lead to improved accuracy of lymph node removal.
Interventions
- PROCEDURE robot-assisted laparoscopic surgery
- DRUG indocyanine green solution
- OTHER diffuse optical imaging
- PROCEDURE therapeutic lymphadenectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-07-25 |
| Est. Completion | 2018-02-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02119858
The ClinicalTrials.gov registry entry for NCT02119858 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which robot-assisted laparoscopic surgery is the first listed.
NCT02119858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02119858 about?
NCT02119858 is a clinical study titled "Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery". This clinical trial studies diffuse optical imaging with indocyanine green solution in imaging pelvic lymph nodes in patients with stage II prostate cancer undergoing surgery. Indocyanine green solution is a special dye that can help doctors see the lymph nodes and blood vessels during surgery when ...
What is the current status of trial NCT02119858?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2014-07-25. Estimated completion is 2018-02-07.
What interventions are being tested in trial NCT02119858?
The interventions under investigation include: robot-assisted laparoscopic surgery (PROCEDURE), indocyanine green solution (DRUG), diffuse optical imaging (OTHER), therapeutic lymphadenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02119858?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.